Commercial octabromodiphenyl ether

3. Decides, in accordance with paragraph 7 (a) of Article 8 of the Convention, that the hexa and hepta bromodiphenyl ether components of the commercial octabromodiphenyl ether are likely, as a result of longrange environmental transport, to lead to significant adverse human health and/or environmental effects such that global action is warranted; 4. Decides, in accordance with paragraph 7 (a) of Article 8 of the Convention, and taking into account that a lack of full scientific certainty should not prevent a proposal to list a chemical in the annexes of the Convention from proceeding, that the octa- and nona bromodiphenyl ether components of the commercial octabromodiphenyl ether are likely, as a result of long-range environmental transport, to lead to significant adverse human health and/or environmental effects such that global action is warranted; 5. Decides further, in accordance with paragraph 7 (a) of Article 8 of the Convention and paragraph 29 of decision SC-1/7 of the Conference of the Parties, to establish an intersessional working group to prepare a risk management evaluation that includes an analysis of possible control measures for commercial octabromodiphenyl ether in accordance with Annex F to the Convention; 6. Invites, in accordance with paragraph 7 (a) of Article 8 of the Convention, Parties and observers to submit to the Secretariat the information specified in Annex F for commercial octabromodiphenyl ether before 5 February 2008.